Akamis Bio reports early data from NG-350A Phase Ib trial
The trial aims to assess if NG-350A with CRT increases composite response rates in pMMR LARC versus CRT alone.
Clinical Trials
Agenus announces Phase II results from gastroesophageal cancer therapy
Acerand reports first-in-human trial results for ACE-106 therapy
First patient receives JANX014 dose in Janux’s trial for mCRPC
TG Therapeutics concludes enrolment in Phase III Briumvi trial
Precision receives CTA approval to expand ELIMINATE-B study
Rivus Pharmaceuticals begins patient dosing in Phase II AMPLIFY trial
GlycoNex secures Japan’s PMDA approval for GNX1021 Phase I trial
